{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T13:44:28Z","timestamp":1790948668243,"version":"4.1.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T00:00:00Z","timestamp":1782518400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T00:00:00Z","timestamp":1782518400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1007\/s00228-026-04089-5","type":"journal-article","created":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T02:51:43Z","timestamp":1782528703000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Detection of intravenous drug physicochemical incompatibilities in clinical practice: e-Harvis compared to reference tools"],"prefix":"10.1007","volume":"82","author":[{"given":"Wala","family":"Ammor","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien","family":"Moynard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabien","family":"Lindenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Navas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,27]]},"reference":[{"key":"4089_CR1","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1007\/s40264-013-0090-2","volume":"36","author":"RN Keers","year":"2013","unstructured":"Keers RN, Williams SD, Cooke J, Ashcroft DM (2013) Causes of Medication Administration Errors in Hospitals: a Systematic Review of Quantitative and Qualitative Evidence. Drug Saf 36:1045\u20131067. https:\/\/doi.org\/10.1007\/s40264-013-0090-2","journal-title":"Drug Saf"},{"key":"4089_CR2","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.aucc.2007.10.004","volume":"21","author":"F Fahimi","year":"2008","unstructured":"Fahimi F, Ariapanah P, Faizi M, Shafaghi B, Namdar R, Ardakani MT (2008) Errors in preparation and administration of intravenous medications in the intensive care unit of a teaching hospital: an observational study. Aust Crit Care 21:110\u2013116. https:\/\/doi.org\/10.1016\/j.aucc.2007.10.004","journal-title":"Aust Crit Care"},{"key":"4089_CR3","doi-asserted-by":"publisher","first-page":"300","DOI":"10.12968\/bjon.2010.19.5.47064","volume":"19","author":"M Elliott","year":"2010","unstructured":"Elliott M, Liu Y (2010) The nine rights of medication administration: an overview. Br J Nurs Mark Allen Group 19:300\u2013305. https:\/\/doi.org\/10.12968\/bjon.2010.19.5.47064","journal-title":"Br J Nurs Mark Allen Group"},{"key":"4089_CR4","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1111\/nuf.12252","volume":"53","author":"JH Jones","year":"2018","unstructured":"Jones JH, Treiber LA (2018) Nurses\u2019 rights of medication administration: Including authority with accountability and responsibility. Nurs Forum 53:299\u2013303. https:\/\/doi.org\/10.1111\/nuf.12252","journal-title":"Nurs Forum"},{"key":"4089_CR5","unstructured":"Flacher L (2024) Incompatibilit\u00e9s physico-chimiques m\u00e9dicamenteuses : \u00e9tat de l\u2019art et perspectives. Sciences pharmaceutiques. https:\/\/dumas.ccsd.cnrs.fr\/dumas-04461203"},{"key":"4089_CR6","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.medin.2018.08.004","volume":"44","author":"G Castells Lao","year":"2020","unstructured":"Castells Lao G, Rodr\u00edguez Reyes M, Roura Turet J, Prat Dot M, Soy Muner D, L\u00f3pez Cabezas C (2020) Compatibility of drugs administered as Y-site infusion in intensive care units: A systematic review. Med Intensiva (Engl Ed) 44:80\u201387. https:\/\/doi.org\/10.1016\/j.medin.2018.08.004","journal-title":"Med Intensiva (Engl Ed)"},{"key":"4089_CR7","doi-asserted-by":"publisher","first-page":"1890","DOI":"10.1097\/CCM.0b013e3181e8adcc","volume":"38","author":"S Kanji","year":"2010","unstructured":"Kanji S, Lam J, Johanson C, Singh A, Goddard R, Fairbairn J et al (2010) Systematic review of physical and chemical compatibility of commonly used medications administered by continuous infusion in intensive care units. Crit Care Med 38:1890\u20131898. https:\/\/doi.org\/10.1097\/CCM.0b013e3181e8adcc","journal-title":"Crit Care Med"},{"key":"4089_CR8","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1007\/s00228-021-03112-1","volume":"77","author":"L N\u00e9grier","year":"2021","unstructured":"N\u00e9grier L, Martin Mena A, Lebuffe G, Odou P, Genay S, D\u00e9caudin B (2021) Strategies to prevent drug incompatibility during simultaneous multi-drug infusion in intensive care units: a literature review. Eur J Clin Pharmacol 77:1309\u20131321. https:\/\/doi.org\/10.1007\/s00228-021-03112-1","journal-title":"Eur J Clin Pharmacol"},{"key":"4089_CR9","doi-asserted-by":"publisher","first-page":"348","DOI":"10.2146\/ajhp080059","volume":"66","author":"DW Newton","year":"2009","unstructured":"Newton DW (2009) Drug incompatibility chemistry. Am J Health Syst Pharm 66:348\u2013357. https:\/\/doi.org\/10.2146\/ajhp080059","journal-title":"Am J Health Syst Pharm"},{"key":"4089_CR10","doi-asserted-by":"publisher","first-page":"49","DOI":"10.4103\/0976-0105.134984","volume":"5","author":"A Vijayakumar","year":"2014","unstructured":"Vijayakumar A, Sharon EV, Teena J, Nobil S, Nazeer I (2014) A clinical study on drug-related problems associated with intravenous drug administration. J Basic Clin Pharm 5:49\u201353. https:\/\/doi.org\/10.4103\/0976-0105.134984","journal-title":"J Basic Clin Pharm"},{"key":"4089_CR11","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.accpm.2018.04.003","volume":"38","author":"M Benlabed","year":"2019","unstructured":"Benlabed M, Perez M, Gaudy R, Genay S, Lannoy D, Barth\u00e9l\u00e9my C et al (2019) Clinical implications of intravenous drug incompatibilities in critically ill patients. Anaesth Crit Care Pain Med 38:173\u2013180. https:\/\/doi.org\/10.1016\/j.accpm.2018.04.003","journal-title":"Anaesth Crit Care Pain Med"},{"key":"4089_CR12","doi-asserted-by":"publisher","first-page":"e18","DOI":"10.1016\/j.phclin.2017.01.047","volume":"52","author":"C Tardy","year":"2017","unstructured":"Tardy C, Maison O, Faudel A, Sarfati L, Iroir G, Rioufol C et al (2017) Incompatibilit\u00e9s m\u00e9dicamenteuses physico-chimiques en unit\u00e9s de soins intensifs: \u00e9tat des lieux et mise en place de mesures pr\u00e9ventives. Le Pharmacien Hospitalier et Clinicien 52:e18. https:\/\/doi.org\/10.1016\/j.phclin.2017.01.047","journal-title":"Le Pharmacien Hospitalier et Clinicien"},{"key":"4089_CR13","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1007\/s00228-018-2602-6","volume":"75","author":"O Maison","year":"2019","unstructured":"Maison O, Tardy C, Cabelguenne D, Parat S, Ducastelle S, Piriou V et al (2019) Drug incompatibilities in intravenous therapy: evaluation and proposition of preventive tools in intensive care and hematology units. Eur J Clin Pharmacol 75:179\u2013187. https:\/\/doi.org\/10.1007\/s00228-018-2602-6","journal-title":"Eur J Clin Pharmacol"},{"key":"4089_CR14","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.2146\/ajhp070633","volume":"65","author":"T Bertsche","year":"2008","unstructured":"Bertsche T, Mayer Y, Stahl R, Hoppe-Tichy T, Encke J, Haefeli WE (2008) Prevention of intravenous drug incompatibilities in an intensive care unit. Am J Health Syst Pharm 65:1834\u20131840. https:\/\/doi.org\/10.2146\/ajhp070633","journal-title":"Am J Health Syst Pharm"},{"key":"4089_CR15","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.phacli.2025.01.005","volume":"60","author":"L Germon","year":"2025","unstructured":"Germon L, Chennell P, Sautou V (2025) Optimisation d\u2019un montage de perfusion sur cath\u00e9ter veineux central courte dur\u00e9e et gestion des incompatibilit\u00e9s m\u00e9dicamenteuses en r\u00e9animation adulte. Le Pharmacien Clinicien 60:264\u2013275. https:\/\/doi.org\/10.1016\/j.phacli.2025.01.005","journal-title":"Le Pharmacien Clinicien"},{"key":"4089_CR16","unstructured":"Guignard B, Gschwind L, Fonzo-Christe C (2015) Les incompatibilit\u00e9s m\u00e9dicamenteuses en 2015: encore une mission du pharmacien d\u2019\u00e9tablissement de sant\u00e9? Pharmactuel [Internet]. [cited 2025 Feb 27];48. https:\/\/pharmactuel.com\/index.php\/pharmactuel\/article\/view\/1081. Accessed 27 Feb 2025"},{"key":"4089_CR17","unstructured":"Alter C La perfusion des m\u00e9dicaments injectables, comment le pharmacien clinicien peut-il r\u00e9soudre les probl\u00e8mes pos\u00e9s au d\u00e9cours des soins des patients adultes ? - La SFAR [Internet]. Soci\u00e9t\u00e9 Fran\u00e7aise d\u2019Anesth\u00e9sie et de R\u00e9animation. 2023 [cited 2025 Feb 27]. https:\/\/dev.sfar.org\/la-perfusion-des-medicaments-injectables-comment-le-pharmacien-clinicien-peut-il-resoudre-les-problemes-poses-au-decours-des-soins-des-patients-adultes\/. Accessed 27 Feb 2025"},{"key":"4089_CR18","unstructured":"McEvoy GK, Trissel LA, American Society of Health-System Pharmacists (2017). Handbook on injectable drugs. 19th edition. Bethesda, MD: American Society of Health-System Pharmacists, Inc"},{"key":"4089_CR19","unstructured":"Micromedex - IV Compatibility search [Internet]. [cited 2024 Jul 25]. https:\/\/www.micromedexsolutions.com\/micromedex2\/librarian\/CS\/734255\/ND_PR\/evidencexpert\/ND_P\/evidencexpert\/DUPLICATIONSHIELDSYNC\/3EFB66\/ND_PG\/evidencexpert\/ND_B\/evidencexpert\/ND_AppProduct\/evidencexpert\/ND_T\/evidencexpert\/PFActionId\/evidencexpert.FindIVCompatibility?navitem=topIV&isToolPage=true#\/ivCompatibilitySearch. Accessed 25 Jul 2024"},{"key":"4089_CR20","unstructured":"King\u00ae Guide\/Login [Internet] [cited 2024 Jul 25]. https:\/\/kingguide.com\/kgpa2\/. Accessed 25 Jul 2024"},{"key":"4089_CR21","unstructured":"Tableau de compatibilit\u00e9s en Y - Stabilis 4.0 [Internet]. [cited 2025 May 12]. https:\/\/www.stabilis.org\/TableIncompatibilites.php. Accessed 12 May 2025"},{"key":"4089_CR22","unstructured":"Hopitaux Universitaires Gen\u00e8ve (2018) Compatibilit\u00e9 des m\u00e9dicaments injectables adminsitr\u00e9s en Y [Internet]. https:\/\/www.hug.ch\/pharmacie\/recommandations\/document\/hug_compatadm_dci"},{"key":"4089_CR23","unstructured":"DrugOptimal - D\u00e9tection des Incompatibilit\u00e9s Physico-Chimiques [Internet]. https:\/\/www.drugoptimal.com\/. [cited 2024 Jul 25]. https:\/\/www.drugoptimal.com\/etablissements-de-sante. Accessed 25 Jul 2024"},{"key":"4089_CR24","unstructured":"Legris M-\u00c8, Valiquette M-\u00c8, Lavoie A, Forest J-M, Leclair G Compatibilit\u00e9 physique par \u00e9valuation visuelle du salbutamol injectable lors de son administration en Y. Pharmactuel [Internet]. 2011 [cited 2025 Jul 23];44. https:\/\/pharmactuel.com\/index.php\/pharmactuel\/article\/view\/790. Accessed 23 Jul 2025"},{"key":"4089_CR25","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1515\/pthp-2019-0005","volume":"4","author":"E D\u2019Huart","year":"2019","unstructured":"D\u2019Huart E, Vigneron J, Demor\u00e9 B (2019) Physical Compatibility of Intravenous Drugs Commonly Used in Intensive Care Units: An Observational Study and Physical Compatibility Laboratory Tests on Anti-Infective Drugs. Pharmaceutical Technology in Hospital Pharmacy. De Gruyter 4:29\u201340. https:\/\/doi.org\/10.1515\/pthp-2019-0005","journal-title":"De Gruyter"},{"key":"4089_CR26","doi-asserted-by":"publisher","first-page":"147","DOI":"10.5935\/0103-507X.20160029","volume":"28","author":"NR Marsilio","year":"2016","unstructured":"Marsilio NR, da Silva D, Bueno D (2016) Drug incompatibilities in the adult intensive care unit of a university hospital. Rev Bras Ter Intensiva 28:147\u2013153. https:\/\/doi.org\/10.5935\/0103-507X.20160029","journal-title":"Rev Bras Ter Intensiva"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-026-04089-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00228-026-04089-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-026-04089-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T02:45:28Z","timestamp":1788749128000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00228-026-04089-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,27]]},"references-count":26,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["4089"],"URL":"https:\/\/doi.org\/10.1007\/s00228-026-04089-5","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,27]]},"assertion":[{"value":"30 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they received free access to the King\n                      \u00ae\n                      tool (online trial version) and e-Harvis\n                      \u00ae\n                      tool, the latter being provided exclusively for evaluation purposes, without receiving any remuneration.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"189"}}